Table 3.
Multiple linear regression analyses conducted to assess independent relationships between MPV and clinical variables
|
MPV in total subjects (Q1~Q4) |
MPV in normal FPG subjects (Q1~Q3) |
MPV in prediabetic subjects (Q4) |
||||
|---|---|---|---|---|---|---|
|
n=1876 |
n=1364 |
n=512 |
||||
| β | P-values | β | P-values | β | P-values | |
| FPG (mg/dl) |
0.009 |
P<0.001 |
0.006 |
P<0.05 |
0.020 |
P<0.001 |
| Sex |
0.078 |
NS |
0.073 |
NS |
0.114 |
NS |
| Age (years) |
0.002 |
P<0.05 |
0.003 |
NS |
0.001 |
NS |
| BMI (kg/m2) |
0.004 |
NS |
0.003 |
NS |
0.006 |
NS |
| SBP (mmHg) |
0.001 |
NS |
0.001 |
NS |
0.002 |
NS |
| DBP (mmHg) |
0.002 |
NS |
0.002 |
NS |
0.001 |
NS |
| UA (mg/dl) |
0.021 |
NS |
0.006 |
NS |
0.014 |
NS |
| R2=0.33, adjusted R2= 0.30, P<0.001 | R2=0.19, adjusted R2= 0.14, P<0.001 | R2=0.43, adjusted R2= 0.30, P<0.01 | ||||
FPG, fasting plasma glucose; MPV, mean platelet volume; BMI, body mass index.
SBP, systolic blood pressure; DBP, diastolic blood pressure; UA, uric acid; NS, not significant.